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Abstract
Background: Endeavors to manage obesity have been heavily reliant on controlling energy intake
and expenditure equilibrium, but have failed to curtail the overweight and obesity epidemic. This
dynamic equilibrium is more complex than originally postulated and is influenced by lifestyle, calorie
and nutrient intake, reward cravings and satiation, energy metabolism, stress response capabilities,
immune metabolism and genetics. Fat metabolism is an important indicator of how efficiently and
to what extent these factors are competently integrating. We investigated whether an Irvingia
gabonensis seed extract (IGOB131) would provide a more beneficial comprehensive approach
influencing multiple mechanisms and specifically PPAR gamma, leptin and adiponectin gene
expressions, important in anti-obesity strategies.
Methods: Using murine 3T3-L1 adipocytes as a model for adipose cell biology research, the effects
of IGOB131 were investigated on PPAR gamma, adiponectin, and leptin. These adipocytes were
harvested 8 days after the initiation of differentiation and treated with 0 to 250 microM of
IGOB131 for 12 and 24 h at 37 degree C in a humidified 5 percent CO2 incubator. The relative
expression of PPAR gamma, adiponectin, and leptin in 3T3-L1 adipocytes was quantified
densitometrically using the software LabWorks 4.5, and calculated according to the reference
bands of beta-actin.
Results: The IGOB131 significantly inhibited adipogenesis in adipocytes. The effect appears to be
mediated through the down-regulated expression of adipogenic transcription factors (PPAR
gamma) [P less than 0.05] and adipocyte-specific proteins (leptin) [P less than 0.05], and by up-
regulated expression of adiponectin [P less than 0.05].
Conclusion: IGOB131 may play an important multifaceted role in the control of adipogenesis and
have further implications in in-vivo anti obesity effects by targeting the PPAR gamma gene, a known
contributory factor to obesity in humans.
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Background
Endeavors to manage obesity have been heavily reliant on
controlling energy intake and expenditure equilibrium,
but have failed to curtail the overweight and obesity epi-
demic. This dynamic equilibrium is more complex than
originally postulated and is influenced by lifestyle, calorie
and nutrient intake, reward cravings and satiation, energy
metabolism, stress response capabilities, immune metab-
olism and genetics. Fat metabolism is an important indi-
cator of how efficiently and to what extent these factors
are competently integrating. Obesity is a condition in
which adipocytes accumulate a large amount of fat and
become enlarged. It is characterized at the cellular level by
an increase in the number and size of adipocytes differen-
tiated from fibroblastic preadipocytes in adipose tissue
[1].
The adipocyte is the primary site for energy storage, which
accumulates triglycerides due to factors that include nutri-
tional excess (energy imbalance), nutrient deficiencies,
excessive stress, and genetic predispositions among other
causes. Shimomura et al. [2] indicated that adipocytes
synthesize and secrete biologically active molecules called
adipocytokines. During adipocyte differentiation, tran-
scriptional factors such as peroxisome proliferator-acti-
vated receptor gamma (PPARγ) are involved in the
sequential expression of adipocyte-specific proteins [3].
Adiponectin is an adipocytokine that has been shown to
have antiatherogenic, anti-inflammatory, and antidia-
betic roles [4]. It has been found to be an important mod-
ulator of insulin sensitivity [5]. Nakamura et al. [6]
indicated that high circulating levels of adiponectin might
be protective against the development of coronary artery
disease. Adiponectin levels are inversely correlated to
body fat percentage, indicating that adiponectin plays an
important role in fatty acid catabolism. Yamauchi et al.
[7] indicated that adiponectin has emerged most recently
as an important adipocytokine with insulin-sensitizing
effects and represents a novel treatment target for insulin
resistance and type 2 diabetes. Leptin is a secreted protein
hormone that affects the hypothalamus to inhibit food
intake and stimulates thermogenesis [8]. The cytosolic
enzyme Glycerol-3-Phosphate Dehydrogenase (G3PDH)
appears to have an important role catalyzing the conver-
sion of glycerol into triglyceride [9].
In the present study, we investigated the effects of a pro-
prietary extract of OB131 Irvingia gabonensis (IGOB131)
on the inhibition of intracellular triglyceride and G3PDH
activity in 3T3-L1 adipocytes. We also examined the effect
of these compounds on protein expression of adipogene-
sis in 3T3-L1 adipocytes.
Methods
Cell Culture
A murine 3T3-L1 cell line was used in this study due to its
widespread acceptance as a cell model for adipose cell
biology research over the course of several decades [10].
3T3-L1 preadipocytes (BCRC 60159) were purchased
from the Bioresource Collection and Research Center
(BCRC, Food Industry Research and Development Insti-
tute, Hsinchu, Taiwan, ROC). 3T3-L1 preadipocytes were
planted into 6-well plates and maintained in DMEM sup-
plemented with 10% bovine calf serum at 37°C in a
humidified 5% CO2 incubator. Adipocytic differentiation
was induced by the adipogenic agents (0.5 mM IBMX, 1
μM DEX, and 1 μM INS) that were added to culture
medium. Afterwards, the medium was changed to normal
culture medium and was freshly replaced every 48 h. The
cells were harvested 8 days after the initiation of differen-
tiation.
Triglyceride Content
Cells were incubated with 250 μM of IGOB131 for 72 h at
37°C in a humidified 5% CO2 incubator. Cells were col-
lected and lysed in lysis buffer (1% Triton X-100 in PBS).
The total triglyceride content in cells was determined
using a commercial triglyceride assay kit (DiaSys Diagnos-
tic Systems GmbH, Holzheim, Germany). The protein
concentration was determined by using a BioRad DC pro-
tein assay kit (Bio-Rad Laboratories, Hercules, CA). Inhi-
bition (%) was expressed as percent decrease in
triglyceride content against control (0%).
Glycerol-3-Phosphate Dehydrogenase Activity
3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation and were incubated with 250 μM of
IGOB131 for 72 h at 37°C in a humidified 5% CO2 incu-
bator. Cells were washed twice with ice-cold PBS on 3T3-
L1 adipocytes, and lysed in 25 mM Tris/1 mM EDTA, pH
7.5 for the measurement of glycerol-3-phosphate dehy-
drogenase (G3PDH) specific activity. G3PDH activity was
determined according to the procedure of Wise and Green
[11]. Protein concentration was determined by the Bio-
Rad DC protein assay kit (Bio-Rad Laboratories, Hercules,
CA) using bovine serum albumin as a standard. Enzyme
activity was expressed as units of activity/mg protein. Inhi-
bition (%) was expressed as percent decrease in G3PDH
activity against control (0%).
Western Blot Assay
Cells were incubated with 0–250 μM of IGOB131 acids
for 12 and 24 h at 37°C in a humidified 5% CO2 incuba-
tor. They were collected and lysed in ice-cold lysis buffer
(20 mM tris-HCl (pH 7.4), 2 mM EDTA, 500 μM sodium
orthovanadate, 1% Triton X-100, 0.1% SDS, 10 mM NaF,
10 μg/mL leupeptin and 1 mM PMSF). The protein con-
centration was estimated with the Bio-Rad DC proteinLipids in Health and Disease 2008, 7:44 http://www.lipidworld.com/content/7/1/44
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assay (Bio-Rad Laboratories, Hercules, CA) using bovine
serum albumin as a standard. Total protein (50–60 μg)
was separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) using a 12% polyacryla-
mide gel. The proteins in the gel were transferred to a
PVDF membrane. The membrane was blocked with 5%
skim milk in PBST (0.05% v/v Tween-20 in PBS, pH 7.2)
for 1 h. Membranes were incubated with primary anti-
body at 4°C overnight and then with secondary antibody
for 1 h. Membranes were washed in PBST for 10 min three
times between each step. The signal was detected using the
Amersham ECL system (Amersham-Pharmacia Biotech,
Arlington Heights, IL). The relative expression of PPARγ,
adiponectin, and leptin in 3T3-L1 adipocytes was quanti-
fied densitometrically using the software LabWorks 4.5,
and calculated according to the reference bands of β-actin.
Statistical analysis
Values are expressed as mean_S.E. For multiple compari-
sons, a one-way analysis of variance (ANOVA) was used.
When ANOVA showed significant differences, post-hoc
analysis was performed with the Newman-Keuls multiple
range test using SPSS.
Results
Effect of IGOB131 on the inhibition of Intracellular 
Triglycerides and G3PDH activity in 3T3-l1 adipocytes
The effect of IGOB131 on percent intracellular triglyceride
and G3PDH levels were evaluated as indicated in the
method section and the results are presented in Table 1.
The reported values are the means ± SD of three samples.
For this study cellular harvesting and incubation was
accomplished with IGOB131 as previously described in
the method section. We found that IGOB131 resulted in a
significant inhibition of intracellular triglycerides (p <
0.05). The peak inhibition using 250 μM of IGOB131 for
72 h at 37°C in 5% CO2 incubator was 80.9 ± 0.7. More-
over we found a similar finding utilizing the same param-
eters for the intracellular G3PHD levels. We found that
IGOB131 resulted in a significant inhibition of intracellu-
lar G3PDH (p < 0.05). The peak inhibition using 250 μM
of IGOB131 for 72 h at 37°C in 5% CO2 incubator was
71.6 ± 1.2 (see Table 1).
Effect of IGOB131 on protein levels of PPARγ, 
adiponectin, and leptin in 3T3-L1 adipocytes
PPARγ
Effect of IGOB131 on protein levels of PPARγ, adiponec-
tin, and leptin in 3T3-L1 adipocytes. 3T3-L1 adipocytes
were harvested 8 days after the initiation of differentia-
tion. Cells were treated with 0–250 μM of IGOB131 for 12
and 24 h at 37°C in a humidified 5% CO2 incubator. The
present experiment indicated that IGOB131 treatment sig-
nificantly (P < 0.05) inhibited the expression of PPARγ
protein levels (Figure 1).
Leptin
Effect of IGOB131 on protein levels of leptin in 3T3-L1 adipocytes
3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation. Cells were treated with 0–250 μM
of IGOB131 for 12 and 24 h at 37°C in a humidified 5%
CO2 incubator. In the present study, IGOB131 reduced
the demand for excessive leptin synthesis, reducing circu-
lating serum leptin levels (P < 0.05). (Figure 2)
Adiponectin
Effect of IGOB131 on protein levels of Adiponectin in 3T3-L1 
adipocytes
3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation. Cells were treated with 0–250 μM
of IGOB131 for 12 and 24 h at 37°C in a humidified 5%
CO2 incubator. In the present study, IGOB131 up-regu-
lated the expression of Adiponectin (P < 0.05). (Figure 3)
Discussion
Over the past few decades, obesity has become a global
epidemic in both developed and developing countries. It
is characterized by an increased adipose tissue mass and is
associated with high health risk [1]. The prevalence of
obesity and obesity-related disorders has led to major
research interests in the influence of adipose tissue mass
[12]. The 3T3-L1 cell line is widely used as a model of adi-
pocyte differentiation and adipose biology. Wang and
Jones [13] indicated that the decreased adipocytic lipo-
genesis is one of the mechanisms of proposed antiobesity.
In the present study, we focused on the effects of
IGOB131 on inhibiting adipogenesis in 3T3-L1 adi-
pocytes. The inhibitory effect resulted from the repression
of adipocyte-specific protein expressions.
Table 1: Effect of IGOB131 on the inhibition of Intracellular Triglycerides and G3PDH activity in 3T3-l1 adipocytes.
Compound % Intracellular Triglyceride Inhibition* % Intracellular G3PDH Inhibition
IGOB131 80.9 ± 0.7 71.6 ± 1.2
*Inhibitions (%) are expressed as percentages of the inhibition of control at 0%. 3T3-L1 adipocytes were harvested 8 days after the initiation of 
differentiation. The cells were incubated with 250 μM of IGOB131 for 72 h at 37°C in 5% CO2 incubator. The reported values are the means ± SD 
(n = 3).Lipids in Health and Disease 2008, 7:44 http://www.lipidworld.com/content/7/1/44
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The goal of this research was to study the inhibition of adi-
pogenesis and adipocyte differentiation with IGOB131.
We investigated the effects of IGOB131 on the inhibition
of intracellular triglyceride and G3PDH activity in 3T3-L1
adipocytes. Fasting induces conversion of glycerol into
triglyceride through an induction of several hepatic
enzymes such as G3PDH and glycerol kinase. Tomiyama
et al. [14] indicated that the expression of G3PDH is
induced several fold upon conversion of preadipocytes to
adipocytes, which is the predominant substrate for triglyc-
eride synthesis in adipose tissue. Our data indicated that
the exposure of 3T3-L1 adipocytes to IGOB131 resulted in
lower levels of intracellular triglycerides and G3PDH than
other compounds tested (Table 1).
Adipose tissue is now known to produce and secrete a
PPARγ, which has roles in the early stage of adipocyte dif-
ferentiation, because they are transcriptional factors for
numerous genes [14,15]. Some studies have addressed the
important role that PPARγ plays in the regulation of insu-
lin sensitivity and glucose homeostasis [16]. The present
experiment indicated that IGOB131 treatment inhibited
the expression of PPARγ protein levels (Figure 1), which
demonstrated that adipogenesis was inhibited by affect-
ing the transcriptional factor cascade upstream of PPARγ
expression. Leptin (product of ob gene) that is secreted
from adipocytes and gains access to the brain, reduces
food intake, and increases energy expenditure [7]. Leptin
that is unable to gain access to the brain, due to CRP bind-
ing resulting in leptin resistance, increases hypothalamic
signaling for leptin synthesis, promoting higher levels of
circulating serum leptin. Adiponectin is specifically
expressed in white adipose tissues and is one of the most
important adipocytokines. Adiponectin is an adipocy-
tokine that has been shown to have antiatherogenic, anti-
inflammatory and antidiabetic roles [5]. In the present
study, IGOB131 reduced the demand for excessive leptin
synthesis, reducing circulating serum leptin levels, and
Effect of IGOB131 on protein levels of PPARγ in 3T3-L1 adipocytes Figure 1
Effect of IGOB131 on protein levels of PPARγ in 3T3-L1 adipocytes. 3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation. Cells were treated with 0–250 μM of IGOB131 for 12 and 24 h at 37°C in a humidified 5% CO2 incuba-
tor. The relative expression of PPARγ, in 3T3-L1 adipocytes was quantified densitometrically using the software LabWorks 4.5, 
and calculated according to the reference bands of β-actin. Values are means for three replicated cultures and *p < 0.05 vs. 
control.Lipids in Health and Disease 2008, 7:44 http://www.lipidworld.com/content/7/1/44
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Effect of IGOB131 on protein levels of Leptin in 3T3-L1 adipocytes Figure 2
Effect of IGOB131 on protein levels of Leptin in 3T3-L1 adipocytes. 3T3-L1 adipocytes were harvested 8 days after the initia-
tion of differentiation. Cells were treated with 0–250 μM of IGOB131 for 12 and 24 h at 37°C in a humidified 5% CO2 incuba-
tor. The relative expression of Leptin, in 3T3-L1 adipocytes was quantified densitometrically using the software LabWorks 4.5, 
and calculated according to the reference bands of β-actin. Values are means for three replicated cultures and *p < 0.05 vs. 
control.
Effect of IGOB131 on protein levels of Adiponectin in 3T3-L1 adipocytes Figure 3
Effect of IGOB131 on protein levels of Adiponectin in 3T3-L1 adipocytes. 3T3-L1 adipocytes were harvested 8 days after the 
initiation of differentiation. Cells were treated with 0–250 μM of IGOB131 for 12 and 24 h at 37°C in a humidified 5% CO2 
incubator. The relative expression of Adiponectin in 3T3-L1 adipocytes was quantified densitometrically using the software 
LabWorks 4.5 and calculated according to the reference bands of β-actin. Values are means for three replicated cultures and 
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stimulated the up-regulation of adiponectin at the protein
level (Figures 2, 3). Adiponectin expression would, there-
fore, be regulated by PPARγ transcriptional activity [17].
Conclusion
The inhibitory effects of IGOB131 on 3T3-L1 adipocytes,
as indicated by the decrease in intracellular triglyceride
content and G3PDH activity have been elucidated. It
appears to be mediated through the down-regulated
expression of adipogenic transcription factors (PPARγ)
and adipocyte-specific proteins (leptin), and then the up-
regulated expression of adiponectin. These results indicate
that IGOB131 may play an important role in the control
of adipogenesis and might have further implication in in-
vivo antiobesity effects that exert specific influence on the
PPARγ gene, a known contributory factor to obesity in
humans [18]. This research provides insight into an
important mechanism for combating obesity.
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